The wellness revolution begins in Tampa Bay! Tampa General Hospital (TGH) and the City of Tampa announced a groundbreaking community health and wellness initiative with the goal of making Tampa the ultimate wellness destination in the United States.
Tampa General Hospital and USF Health Morsani College of Medicine physicians are the first in Hillsborough County to bring patients experiencing recurring brain tumors a groundbreaking treatment.
Tampa General Hospital is the only Major Teaching Hospital in Florida – and one of only 15 in the country – to be named to the 2022 Fortune/Merative (formerly IBM Watson Health) 100 Top Hospitals® list.
As part of its vision to be the safest and most innovative academic health system in America, Tampa General Hospital continues to garner awards for excellence, and was just named as a Best Maternity Hospital 2022 by Newsweek magazine.
To improve the quality of home care for its patients, Tampa General Hospital (TGH) is partnering with home health agency, the Visiting Nurse Association, (VNA) to form TGH Home Care powered by VNA of Florida. The new entity will provide a full range of home care services for Tampa General patients, as well as those in the community needing home care.
Tampa General Hospital patients now have a new option for care that combines the expertise of a world-class facility with the comfort of their own home. Tampa General Hospital (TGH)’s Hospital at Home program combines expert care and innovative technology with a focus on the needs of the patient. TGH at Home gives eligible patients an opportunity to stay home, while receiving best-in-class clinical hospital care from health care providers including physicians, physician assistants, nurse practitioners and certified nurse assistants. Based on the same standards used inside the hospital, patients receive daily in-home visits from health care providers, virtual visits and around-the-clock remote patient monitoring.
The USF Tampa General Physicians (USFTGP) has named Matthew Cantonis as its senior vice president of operations.
Launched in January 2022, USFTGP supports the administrative functions of the clinical practices of both the USF Health Morsani College of Medicine and Tampa General Medical Group (TGMG). The creation of the organization follows nearly two years of transition planning since announcing the broadened affiliation in July 2020.
John Couris, president and CEO of Tampa General Hospital,is among Modern Healthcare’s 2022 class of Top Innovators. Modern Healthcare, the leader in health care business news, research and data, annually recognizes leaders who are instituting innovation and leading transformative programs that improve care by achieving measurable results and contributing to the clinical and financial goals of their organization.
The board of directors for the USF Tampa General Physicians has named Mark G. Moseley, MD, MHA, FACEP, the first president of the newly formed academic medical group. Dr. Moseley will assume the new position April 11, 2022.
“Dr. Moseley is the perfect person to serve as the president of USF Tampa General Physicians. With his deep familiarity of the faculty practice plan and decades of experience in academic health and clinical operations, Dr. Moseley will bring immense value to the role at this critical juncture,” said Charles Lockwood, MD, senior vice president of USF Health and dean of the USF Health Morsani College of Medicine. “As USF Tampa General Physicians grows, Dr. Moseley’s vision and exemplary leadership will be needed to further our mission of providing unparalleled patient care to our region.”
University of South Florida’s (USF) Morsani College of Medicine, in collaboration with Tampa General Hospital (TGH),is pleased to have contributed to the PREVENT-19 trial sponsored by Novavax and the COVID-19 Vaccine Prevention Network, which resulted in the fourth COVID-19 vaccine in the U.S. This vaccine recently received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for individuals 18 years of age and older.
The USF Health Morsani College of Medicine was selected as a trial site in 2020 and began enrolling participants in early 2021. The EUA provides access in the U.S. to the first protein-based COVID-19 vaccine, expanding the options available to the public to include more traditional vaccine technologies.